Emotional disturbance: Acute tension and anxiety states. Agitation, insomnia, anxiety and age related depressive reactions.
Functional disturbance in the cardiovascular respiratory system: pseudoangina pectoris, precordial anxiety, tachycardia, emotiogenic hypertension, dyspnea and hyperventilation.
In the gastrointestinal system: Irritable bowel syndrome, epigastric pain, spasm, bloting diarrhoea, etc.
In the genitourinary system: Irritable bladder and dysmenorrhea.
Psychosomatic disorders: psychogenic headache, psychogenic dermatosis, asthma, gastric and duodenal ulcer, ulcerative colitis. Emotional reactions to chronic organic diseases.
Use in adult: The optimum dosage and frequency of administration of Bromazepam should be based on the individual patient, the severity of symptoms and previous psychotropic drug history. The usual dosage in general practice is from 3 mg to 18 mg daily in divided doses. In exceptional circumstances, in hospitalized patients, up to the maximum daily dosage of 60 mg, in divided doses, may be given.
Use in elderly: Elderly patients are more sensitive to the actions of Bromazepam. Doses should
not exceed half of those normally recommended
Use in children: Bromazepam is not recommended for paediatric use.